North America Electrocardiograph (ECG) Market 2021-2031 by Product Type (Conventional Devices, Emerging Devices, Software & Services), Lead Type (Single-lead, 3-lead, 5-lead, 6-lead, 12-lead), Function (Diagnostic, Monitoring), Technology (Portable, Wireless), End User (Hospitals and Clinics, ASCs, Home-based Users, Cardiac Centers), and Country: Trend Forecast and Growth Opportunity
North America electrocardiograph (ECG) market is projected to grow by 5.5% annually in the forecast period and reach $ 4,246.6 million by 2031, driven by the rising incidences of cardiac disorders and lifestyle related diseases, constantly increasing incidences of casualties due to cardiovascular diseases (CVDs), the increase in geriatric population coupled with behavioral risk factors such as rise in alcohol consumption and smoking, technological advancement and innovations, and the increasing healthcare expenditure. Highlighted with 24 tables and 54 figures, this 113-page report “North America Electrocardiograph (ECG) Market 2021-2031 by Product Type (Conventional Devices, Emerging Devices, Software & Services), Lead Type (Single-lead, 3-lead, 5-lead, 6-lead, 12-lead), Function (Diagnostic, Monitoring), Technology (Portable, Wireless), End User (Hospitals and Clinics, ASCs, Home-based Users, Cardiac Centers), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America electrocardiograph (ECG) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America electrocardiograph (ECG) market in every aspect of the classification from perspectives of Product Type, Lead Type, Function, Technology, End User, and Country. Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Conventional Devices o Resting ECG Devices o Stress ECG Devices • Emerging Devices o Implantable Loop Recorders o Mobile Cardiac Telemetry o Holter Monitors o Cardiac Event Monitors o Smart ECG Monitors • Software & Services Based on Lead Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Single-Lead Type ECG Devices • 3-Lead Type ECG Devices • 5-Lead Type ECG Devices • 6-Lead Type ECG Devices • 12-Lead Type ECG Devices • Other Lead Types By Function, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic ECG Systems • Monitoring ECG Systems By Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Portable ECG Systems • Wireless ECG Systems By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Clinics • Ambulatory Surgical Centers (ASCs) • Home-based Users • Cardiac Centers • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Lead Type and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories ACS Diagnostics Biotricity, Inc. BIOTRONIK SE & Co. KG Boston Scientific Corporation CardioComm Solutions, Inc. Cardioline SpA Edan Instruments, Inc. Fukuda Denshi Co., Ltd. General Electric Company Hill-Rom Holdings, Inc. iRhythm Technologies, Inc. Koninklijke Philips N.V. Medtronic plc Mindray Medical International Limited Nihon Kohden Corporation OSI Systems, Inc. Schiller AG Suzuken Co., Ltd. Zoll Medical Corporation (Asahi Kasei Corporation) (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7 1.1 Industry Definition and Research Scope 7 1.1.1 Industry Definition 7 1.1.2 Research Scope 8 1.2 Research Methodology 11 1.2.1 Overview of Market Research Methodology 11 1.2.2 Market Assumption 12 1.2.3 Secondary Data 12 1.2.4 Primary Data 12 1.2.5 Data Filtration and Model Design 13 1.2.6 Market Size/Share Estimation 14 1.2.7 Research Limitations 15 1.3 Executive Summary 16 2 Market Overview and Dynamics 19 2.1 Market Size and Forecast 19 2.1.1 Impact of COVID-19 on World Economy 21 2.1.2 Impact of COVID-19 on the Market 23 2.2 Major Growth Drivers 25 2.3 Market Restraints and Challenges 31 2.4 Emerging Opportunities and Market Trends 34 2.5 Porter’s Fiver Forces Analysis 38 3 Segmentation of North America Market by Product Type 42 3.1 Market Overview by Product Type 42 3.2 Conventional Devices 44 3.2.1 Resting ECG Devices 45 3.2.2 Stress ECG Devices 46 3.3 Emerging Devices 47 3.3.1 Implantable Loop Recorders 49 3.3.2 Mobile Cardiac Telemetry 50 3.3.3 Holter Monitors 51 3.3.4 Cardiac Event Monitors 52 3.3.5 Smart ECG Monitors 53 3.4 Software & Services 54 4 Segmentation of North America Market by Lead Type 55 4.1 Market Overview by Lead Type 55 4.2 Single-Lead Type ECG Devices 57 4.3 3-Lead Type ECG Devices 58 4.4 5-Lead Type ECG Devices 59 4.5 6-Lead Type ECG Devices 60 4.6 12-Lead Type ECG Devices 61 4.7 Other Lead Types 62 5 Segmentation of North America Market by Function 63 5.1 Market Overview by Function 63 5.2 Diagnostic ECG Systems 65 5.3 Monitoring ECG Systems 66 6 Segmentation of North America Market by Technology 67 6.1 Market Overview by Technology 67 6.2 Portable ECG Systems 69 6.3 Wireless ECG Systems 70 7 Segmentation of North America Market by End User 71 7.1 Market Overview by End User 71 7.2 Hospitals and Clinics 73 7.3 Ambulatory Surgical Centers (ASCs) 74 7.4 Home-based Users 75 7.5 Cardiac Centers 76 7.6 Other End Users 77 8 North America Market 2021-2031 by Country 78 8.1 Overview of North America Market 78 8.2 U.S. 81 8.3 Canada 84 8.4 Mexico 86 9 Competitive Landscape 88 9.1 Overview of Key Vendors 88 9.2 New Product Launch, Partnership, Investment, and M&A 91 9.3 Company Profiles 92 Abbott Laboratories 92 ACS Diagnostics 94 Biotricity, Inc. 95 BIOTRONIK SE & Co. KG 96 Boston Scientific Corporation 97 CardioComm Solutions, Inc. 98 Cardioline SpA 99 Edan Instruments, Inc. 100 Fukuda Denshi Co., Ltd. 101 General Electric Company 102 Hill-Rom Holdings, Inc. 103 iRhythm Technologies, Inc. 104 Koninklijke Philips N.V. 105 Medtronic plc 106 Mindray Medical International Limited 107 Nihon Kohden Corporation 108 OSI Systems, Inc. 109 Schiller AG 110 Suzuken Co., Ltd. 111 Zoll Medical Corporation (Asahi Kasei Corporation) 112 RELATED REPORTS 113